Literature DB >> 26212251

Idiopathic interstitial pneumonias with connective tissue diseases features: A review.

Vincent Cottin1,2,3,4.   

Abstract

A systematic approach is recommended to search for clinical and biological features of connective tissue disease (CTD) in any patient with interstitial lung disease (ILD). In the diagnostic approach to ILD, a diagnosis of CTD should be considered particularly in women and subjects younger than 50 years, and in those with an imaging and/or pathological pattern of non-specific interstitial pneumonia. However, the diagnosis of CTD may be difficult when ILD is the presenting or the dominant manifestation of CTD. A proportion of patients with ILD present symptoms that belong to the spectrum of CTD and/or biological autoimmune features, but do not fulfil diagnostic criteria for a given CTD. Some imaging and histopathological patterns may also suggest the presence of an underlying CTD. Although studies published to date used heterogeneous definitions and terminology for this condition, evidence is accumulating that even limited CTD features are relevant regarding symptoms, imaging features, pathological pattern and possibly evolution to overt CTD, whereas the impact on prognosis needs confirmation. Conversely, autoantibodies alone do not seem to impact the prognosis or management in patients with otherwise typical idiopathic pulmonary fibrosis and no extra-pulmonary manifestation. A collective international multidisciplinary effort has proposed a uniform definition and criteria for 'interstitial pneumonia with autoimmune features', a condition characterized by limited CTD features occurring in the setting of ILD, with the aim of fostering future clinical studies. Referral of ILD patients suspect to have CTD to a rheumatologist and possibly multidisciplinary discussion may contribute to a better management.
© 2015 Asian Pacific Society of Respirology.

Entities:  

Keywords:  connective tissue disease; idiopathic inflammatory myopathy; interstitial lung disease; rheumatoid arthritis; undifferentiated connective tissue disease

Mesh:

Year:  2015        PMID: 26212251     DOI: 10.1111/resp.12588

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  17 in total

1.  Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists.

Authors:  Sarah Geerts; Wim Wuyts; Ellen De Langhe; Jan Lenaerts; Jonas Yserbyt
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 2.  Acute exacerbation of interstitial lung disease associated with rheumatic disease.

Authors:  Fabrizio Luppi; Marco Sebastiani; Carlo Salvarani; Elisabeth Bendstrup; Andreina Manfredi
Journal:  Nat Rev Rheumatol       Date:  2021-12-07       Impact factor: 20.543

Review 3.  Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.

Authors:  So-My Koo; Soo-Taek Uh
Journal:  Korean J Intern Med       Date:  2017-06-30       Impact factor: 2.884

4.  Emodin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Anti-Inflammatory and Anti-Oxidative Activities in Rats.

Authors:  Sheng-Lan Tian; Yang Yang; Xiao-Liu Liu; Qing-Bang Xu
Journal:  Med Sci Monit       Date:  2018-01-01

Review 5.  Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).

Authors:  Adelle S Jee; Stephen Adelstein; Jane Bleasel; Gregory J Keir; MaiAnh Nguyen; Joanne Sahhar; Peter Youssef; Tamera J Corte
Journal:  J Clin Med       Date:  2017-05-04       Impact factor: 4.241

6.  Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?

Authors:  Giacomo Grasselli; Beatrice Vergnano; Maria Rosa Pozzi; Vittoria Sala; Gabriele D'Andrea; Vittorio Scaravilli; Marco Mantero; Alberto Pesci; Antonio Pesenti
Journal:  Ann Intensive Care       Date:  2017-09-18       Impact factor: 6.925

7.  Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.

Authors:  Weibin Qian; Xinrui Cai; Qiuhai Qian; Wei Zhang; Dongli Wang
Journal:  J Cell Mol Med       Date:  2018-07-04       Impact factor: 5.310

Review 8.  Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease.

Authors:  So My Koo; Song Yee Kim; Sun Mi Choi; Hyun Kyung Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-05-31

9.  Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype.

Authors:  Julia Graham; Iazsmin Bauer Ventura; Chad A Newton; Cathryn Lee; Noelle Boctor; Janelle Vu Pugashetti; Claire Cutting; Elena Joerns; Habrinder Sandhu; Jonathan H Chung; Christine Kim Garcia; Michael Kadoch; Imre Noth; Ayodeji Adegunsoye; Mary E Strek; Justin M Oldham
Journal:  Eur Respir J       Date:  2020-07-16       Impact factor: 16.671

Review 10.  Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?

Authors:  Domenico Sambataro; Gianluca Sambataro; Francesca Pignataro; Giovanni Zanframundo; Veronica Codullo; Evelina Fagone; Emanuele Martorana; Francesco Ferro; Martina Orlandi; Nicoletta Del Papa; Lorenzo Cavagna; Lorenzo Malatino; Michele Colaci; Carlo Vancheri
Journal:  Diagnostics (Basel)       Date:  2020-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.